Moreover, BRCA2 PVs were associated with three- to fourfold increased risks of pancreatic and stomach cancers in both sexes [34], as well as with a twofold increased risk of prostate cancer, with a cumulative risk to age 80 years of 27% for male BRCA2 PV carriers [34]. This evidence concerns the gene BRCA2 and prostate carcinoma.